Penciclovir

Penciclovir

SCHEMBL4240104

Nc1nc2c(ncn2CCC(CO)CO)c(=O)[nH]1.O=P(O)(O)O

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Penciclovir. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 9/20 0.66
PNP P00491 7/20 0.65
TK1 P04183 1/20 0.65
MEN1 O00255 1/20 0.61
ALDH1A1 P00352 1/20 0.61
LMNA P02545 1/20 0.61
CYP3A4 P08684 1/20 0.61
NFKB1 P19838 1/20 0.61
BLM P54132 1/20 0.61
VCP P55072 1/20 0.61
KMT2A Q03164 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HIF1A Q16665 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Penciclovir SCHEMBL454090 1.00 HPRT1 (0.66) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL3495 0.95 TK1 (0.70) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL7192792 0.94 TK1 (0.69) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL583037 0.94 TK1 (0.69) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL10414021 0.94 TK1 (0.69) HPRT1PNPTK1MEN1ALDH1A1
Buciclovir SCHEMBL571385 0.91 HPRT1 (0.67) HPRT1PNPTK1MEN1ALDH1A1
SCHEMBL10508817 0.91 TK1 (0.68) HPRT1PNPTK1MEN1ALDH1A1
Penciclovir SCHEMBL28339260 0.91 TK1 (0.65) HPRT1PNPTK1MEN1ALDH1A1
SCHEMBL6268539 0.91 TK1 (0.65) HPRT1PNPTK1MEN1ALDH1A1
SCHEMBL7196190 0.90 HPRT1 (0.58) HPRT1PNPTK1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4190312-A1 SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE AGENTS INTO NANOPARTICLES Karlsruher Institut für Technologie (DE) 2023-06-07 EP claimed
EP-0152316-B1 SUBSTITUTED BUTYL GUANINES AND THEIR UTILIZATION IN ANTIVIRAL COMPOSITIONS MERCK & CO. INC. (US) 1989-07-26 EP claimed
WO-2023104380-A1 SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES Karlsruher Institut für Technologie (DE) 2023-06-15 WO disclosed
EP-4190312-A1 SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE AGENTS INTO NANOPARTICLES Karlsruher Institut für Technologie (DE) 2023-06-07 EP disclosed
CN-109627243-B Penciclovir-copper complex, synthetic method and application thereof 广西壮族自治区水产科学研究院 2021-06-29 CN disclosed
CN-108033987-B Method for synthesizing houttuynin heterozygotic flavone Houttuynoid A 暨南大学 2019-12-24 CN disclosed
CN-109627243-A A kind of Penciclovir-copper complex, synthetic method and its application 广西壮族自治区水产科学研究院 2019-04-16 CN disclosed
CN-108101895-A A kind of derivative, the preparation method and the usage of decanoy acetaldehyde heterozygosis flavones Houttuynoid A 暨南大学 2018-06-01 CN disclosed
CN-108033987-A A kind of method of sodium houttuyfonate heterozygosis flavones Houttuynoid A 暨南大学 2018-05-15 CN disclosed
CN-102153606-B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof LIANYUNGANG DUXIANG CHEMICAL CO LTD 2013-07-17 CN disclosed
CN-102423488-B Medicine composition used for treating herpes zoster SHIJIAZHUANG ZHONGSHUO PHARMACEUTICAL GROUP CO LTD 2013-07-10 CN disclosed
CN-101468014-B Technique for preparing penciclovir emulsifiable paste Shanghai Fosun Pharmaceutical (Group) Limited by Share Ltd. (CN) 2012-02-15 CN disclosed
CN-102153606-A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof LIANYUNGANG DUXIANG CHEMICAL CO LTD 2011-08-17 CN disclosed
CN-100594889-C Penciclovir freeze dried and method of manufacturing the same Zhejiang jianfeng pharmaceutical co ltd 2010-03-24 CN disclosed
CN-101468014-A Technique for preparing penciclovir emulsifiable paste SHANGHAI FOSUN PHARMACEUTICAL (CN) 2009-07-01 CN disclosed
US-20090099154-A1 Pharmaceutical Sustained Release Compositions and Processes Thereof PANACEA BIOTEC LTD. (IN) 2009-04-16 US disclosed
EP-1912628-A2 PHARMACEUTICAL SUSTAINED RELEASE COMPOSITIONS AND PROCESSES THEREOF Panacea Biotec Ltd. (IN) 2008-04-23 EP disclosed
CN-101108169-A Penciclovir freeze dried and method of manufacturing the same ZHEJIANG JIAFENG PHARMACEUTICA (CN) 2008-01-23 CN disclosed
WO-2007000779-A2 PHARMACEUTICAL SUSTAINED RELEASE COMPOSITIONS AND PROCESSES THEREOF PANACEA BIOTEC LTD. (IN) 2007-01-04 WO disclosed
CN-1615874-A Penciclovir solution and its preparing method and use HE JIANG (CN) 2005-05-18 CN disclosed